- Home
- TBPH vs NFGC Comparison
TBPH vs NFGC Comparison
Compare TBPH & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBPH | NFGC |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 928.8M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TBPH | NFGC |
|---|---|---|
| Price | $16.97 | $2.18 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.40 | N/A |
| AVG Volume (30 Days) | 307.5K | ★ 1.7M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | $3,542.00 |
| Revenue Next Year | N/A | $118.57 |
| P/E Ratio | $8.25 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.33 | $1.19 |
| 52 Week High | $21.03 | $3.59 |
Technical Indicators
Market Signals| Indicator | TBPH | NFGC |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 54.37 |
| Support Level | $16.14 | $1.85 |
| Resistance Level | $17.24 | $2.34 |
| Average True Range (ATR) | 0.40 | 0.12 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 85.51 | 67.78 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).